📰 David Hung News
Page 4 - David Hung News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from David Hung. Real-time updates on events, politics, business and more.
June 27, 2022
Nuvation Bio Inc. , a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the Food and Drug... | June 27, 2022
April 15, 2022
14.04.2022 - MARKHAM, Ontario, April 14, 2022 (GLOBE NEWSWIRE) - Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced that it will report its 2022 first quarter results after market close on Thursday, May 12, 2022. Nitin Jain, President ...
April 15, 2022
MARKHAM, Ontario, April 14, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") SIA announced that it will report its 2022
April 14, 2022
MARKHAM, Ontario, April 14, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced that it will report its...
January 20, 2022
/PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated...
January 20, 2022
/PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated...
January 10, 2022
David Hung, M.D., founder, president, and chief executive officer, to present virtually at the 40th Annual J.P. Morgan Healthcare Conference on January 11,...
December 15, 2021
/PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated...
December 13, 2021
/PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated...
June 1, 2021
Published: Jun 01, 2021 Experienced technical operations and CMC leader brings scientific and strategic expertise in oncology drug development and life cycle management NEW YORK, June 1, 2021 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the appointment of David C. Hanley, Ph.D., as Chief Technical Operations Officer, joining the...